Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02211014
Title An Open-Label, Phase 1b Study of ACP-196 With and Without Dexamethasone in Subjects With Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acerta Pharma BV
Indications

multiple myeloma

Therapies

Acalabrutinib

Dexamethasone

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Baltimore Maryland United States Details
United Kingdom Leicester United Kingdom Details
Guys and St Thomas' Hospital NHS Foundation Trust London United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field